The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurface Transforms Regulatory News (SCE)

Share Price Information for Surface Transforms (SCE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.225
Bid: 1.20
Ask: 1.25
Change: -0.025 (-1.96%)
Spread: 0.05 (4.167%)
Open: 1.30
High: 1.35
Low: 1.25
Prev. Close: 1.275
SCE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Replacement announcement - director dealings

8 Jan 2021 17:13

RNS Number : 1440L
Surface Transforms PLC
08 January 2021
 

8 January 2021

Surface Transforms plc.

("Surface Transforms" or the "Company")

 

Replacement announcement - Director Dealings

Surface Transforms (AIM: SCE), announced that on 8 January 2021, the Company received notification from Kevin D'Silva, non-executive director of the Company, that he is beneficially interested in 1,260,315 ordinary shares of 1p each in the Company ("Ordinary Shares"), equivalent to 0.81% of the Company's total issued share capital.

On 1 June 2020, the Company issued an RNS entitled "Director Dealings" (RNS number: 4468O) which disclosed Kevin D'Silva's beneficial interest as being 1,283,141 Ordinary Shares. This was incorrect; his beneficial interest should have been disclosed as being 1,260,315 Ordinary Shares.

For enquiries, please contact:

Surface Transforms plc +44 151 356 2141 

David Bundred, Chairman

Kevin Johnson, CEO

Michael Cunningham, CFO

 

Zeus Capital Limited (Nominated Adviser and Joint Broker) +44 203 829 5000

 

David Foreman / Dan Bate/ Jordan Warburton (Corporate Finance)

Dominic King (Corporate Broking)

 

finnCap Ltd (Joint-Broker) +44 20 7220 0500

Ed Frisby / Giles Rolls (Corporate Finance)Richard Chambers (ECM)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDKFBKOBKDCDK
Date   Source Headline
5th May 20237:00 amRNSDirector Dealing
27th Apr 202312:35 pmEQSHardman & Co Video | Surface Transforms (SCE) Presentation and Q&A with the Board
24th Apr 20237:00 amRNSDirector dealing and total voting rights
24th Apr 20237:00 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSPreliminary Results and Notice of AGM
6th Apr 202312:45 pmEQSHardman Talks Video Event | Surface Transforms Management Presentation and Q&A
3rd Apr 20237:00 amRNSProduction, Capacity and Trading Update
27th Jan 20232:34 pmRNSHolding(s) in Company
11th Jan 20237:00 amRNSTrading and operations update
20th Dec 20227:00 amRNSDirectorate Change
19th Dec 20227:00 amRNSPDMR Share Dealing & Total Voting Rights
15th Dec 202210:22 amEQSHardman & Co Research : Surface Transforms (SCE): Major OEM 10 order, OEM 8 delay resolved
24th Nov 20227:00 amRNSOEM 10 Contract Award and Trading Update
9th Nov 20224:42 pmRNSExercise of Options
27th Oct 202211:05 amRNSHolding(s) in Company
24th Oct 202211:15 amRNSHolding(s) in Company
20th Oct 20228:01 amRNSDirector Dealing
19th Oct 202212:23 pmRNSResult of General Meeting & Total Voting Rights
19th Oct 20227:00 amRNSResult of Open Offer
6th Oct 20222:20 pmEQSHardman & Co Research on Surface Transforms (SCE): The large growth is now self-financing
6th Oct 202212:05 pmEQSHardman & Co: Hardman Talks Video | Surface Transforms Surface Transforms presentation and Q&A with the Board
30th Sep 202211:02 amRNSInvestor Presentation
29th Sep 20221:25 pmEQSHardman & Co Research : Hardman Talks Video Event | Surface Transforms Management Presentation and Q&A
29th Sep 20228:33 amRNSResult of Placing, Open Offer Launch & GM Notice
28th Sep 20225:03 pmRNSProposed Placing, Subscription and Open Offer
12th Sep 202212:00 pmEQSHardman & Co Q&A on Surface Transforms (SCE): It's all in the detail
6th Sep 20227:15 amEQSHardman & Co Research on Surface Transforms (SCE): Further new order, upgrades, production ramp-up
5th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSContract award from OEM 9
19th Aug 20227:00 amRNSRetirement of non-executive director
17th Aug 20225:48 pmRNSExercise of options
13th Jul 20227:00 amRNSGrant of Options
6th Jul 20227:00 amRNSTrading Statement & Sales and Operations Update
30th Jun 20226:21 pmRNSResult of AGM
30th Jun 20227:00 amRNSAGM Statement and Sales & Operations Presentation
21st Jun 20227:00 amRNSAdditional Capital Markets Day & Presentation
27th May 20222:46 pmRNSDirector/PDMR Shareholding
25th May 20227:00 amRNSDirector/PDMR Shareholding
23rd May 202210:58 amRNSPosting of Annual Report and Notice of AGM
10th May 202212:05 pmEQSHardman & Co: Hardman Talks Video | Surface Transforms Surface Transforms’ Capital Markets Day presentation with the Board
6th May 202210:43 amRNSPresentation to Mello Investor evening
25th Apr 20224:05 pmEQSHardman & Co Research: Surface Transforms (SCE) Growth rate and visibility enhanced even further
22nd Apr 20227:00 amRNSSurface Transforms plc Ian Cleminson appointment
11th Apr 202211:00 amEQSHardman & Co Research : Hardman Talks Video Event | Surface Transforms Management Presentation and Q&A
4th Apr 20227:00 amRNSPreliminary Results and Notice of AGM
31st Mar 20227:00 amRNSAdditional Capital Markets Day
24th Mar 20229:05 amRNSSecond Price Monitoring Extn
24th Mar 20229:00 amRNSPrice Monitoring Extension
24th Mar 20227:01 amRNSCapital Markets Day
24th Mar 20227:00 amRNSNew OEM 8 Contract for Additional Sales

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.